• Golimumab for Type 1 Diabetes; Long-Term Success for Oral Octreotide

    6 days ago - By MedPageToday

    Subcutaneous treatment with the human monoclonal antibody golimumab helped kids and young adults newly diagnosed with type 1 diabetes use less insulin, according to a 52-week phase II study. (New England Journal of...
    Read more ...

     

  • Race disparities persist in CGM use among children with type 1 diabetes

    Race disparities persist in CGM use among children with type 1 diabetes

    6 days ago - By Healio

    White children with type 1 diabetes are twice as likely to initiate continuous glucose monitoring and four times as likely to persist with therapy at 1 year compared with Black and Hispanic children, regardless of insurance type, data show.
    “Many studies have shown that non-Hispanic Black children with type 1 diabetes are less likely to use continuous glucose monitors; we wanted to see if this was also the case in our center,” Colin P. Hawkes, MD, PhD, consultant pediatric endocrinologist at Cork University Hospital, Ireland, and adjunct assistant professor at the University of
    Read more ...